CD4 and neoplasm: In fact, CD4+CD25+ T cell depletion is known to transiently activate CD8+ T cells [53], and it is plausible that the interaction between these activated CD8+ T cells and ULBP2-expressing tumor cells was enhanced, resulting in chronic NKG2D stimulation.